A preliminary study to evaluate patient outcomes, feasibility, preliminary effectiveness, safety and economic evaluation of Korean medicine treatment for periodontal disease

Dongguk University Ilsan Oriental Hospital0 个研究点目标入组 45 人开始时间: 待定最近更新: 2024年4月2日

试验速览

暂无简介。

•(1) Individuals aged 20 years and above but below 65 years, regardless of gender.
•(2) Those diagnosed with gingivitis and mild periodontitis.
•(3) Individuals who voluntarily provided written consent to this human application trial through the Informed Consent Form.

•(1) Patients with severe or advanced periodontitis.
•(2) Individuals who have undergone scaling and preventive periodontal treatment within the last 3 months from the date of consent form completion.
•(3) Smokers.
•(4) Individuals with orthodontic appliances.
•(5) Those with pathological findings in the oral tissues or requiring treatment from other departments.
•(6) Individuals requiring immediate treatment for dental caries.
•(7) Individuals with uncontrolled chronic conditions such as diabetes, liver disease, heart disease, kidney disease, bleeding disorders, or other chronic illnesses.
•(8) Those with clinically significant immune, infectious, neoplastic, or psychiatric disorders requiring treatment.
•(9) Users of medications that may affect periodontal health (nifedipine, phenytoin, cyclosporine).
•(10) Those who have taken antibiotics within the last 4 weeks, are currently taking antibiotics, or are planning to receive antibiotics in the future.
•(11) Individuals who have received investigational drugs or non-investigational medicinal products for clinical trials within 30 days prior to participating in the clinical trial.
•(12) Pregnant or lactating women, or fertile women not using acceptable contraceptive methods.
•(13) Individuals deemed unsuitable as subjects for this trial by the clinical trial investigator and personnel for reasons other than those mentioned above.

发起方

Dongguk University Ilsan Oriental Hospital